Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 3, 2004, Pages 111-118

  Miyamoto, Tomoyuki ^a   Watanabe, Jun ^a   Hata, Hiroki ^b   Jobo, Toshiko ^a   Kawaguchi, Miwa ^a   Hattori, Manabu ^a   Saito, Mayumi ^a   Kuramoto, Hiroyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Dept of Obstetrics and Gynecology   (Japan)

Author keywords

Clinicopathological parameters; Endometrial adenocarcinoma; Progesterone receptor isoforms; Prognosis

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN P27; PROTEIN P53;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TUMOR CELL;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE;

EID: 8844266113     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.07.007     Document Type: Article

References (36)

1. H. Ishibashi, T. Suzuki, S. Suzuki, T. Moriya, C. Kaneko, T. Takizawa, M. Sunamori, M. Handa, T. Kondo, and H. Sasano Sex steroid hormone receptors in human thymoma J. Clin. Endocrinol. Metab. 88 2003 2309 2317
2. P.A. Mote, J.F. Johnston, T. Manninen, P. Tuohimaa, and C.L. Clarke Detection of progesterone receptor forms A and B by immunohistochemical analysis J. Clin. Pathol. 54 2001 624 630
3. E. Vegeto, M.M. Shahbaz, D.X. Wen, M.E. Goldman, B.W. O'Malley, and D.P. McDonnell Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function Mol. Endocrinol. 7 1993 1244 1255
4. P.G. Rose Endometrial carcinoma N. Eng. J. Med. 335 9 1996 640 649
5. S. Kounelis, N. Kapranos, E. Kouri, D. Coppola, H. Papadaki, and M.W. Jones Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature Mod. Pathol. 13 4 2000 379 388
6. M. Akaboshi, J. Watanabe, T. Fujisawa, M. Hattori, E. Ohno, and H. Kuramoto Immunohistochemical expression of cdk2 and Ki-67 in human endometrial carcinoma J. Jpn. Soc. Clin. Cytol. 40 2001 121 127
7. N. Kato, J. Watanabe, T. Jobo, Y. Nishimura, T. Fujisawa, Y. Kamata, and H. Kuramoto Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance J. Cancer Res. Clin. Oncol. 129 2003 222 226
8. N. Kyushima, J. Watanabe, H. Hata, T. Jobo, T. Kameya, and H. Kuramoto Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables J. Cancer Res. Clin. Oncol. 128 2002 307 312
9. J. Watanabe, H. Sato, T. Kanai, Y. Kamata, T. Jobo, H. Hata, T. Fujisawa, E. Ohno, T. Kameya, and H. Kuramoto Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of uterine corpus - correlation with proliferation and clinicopathological parameters Br. J. Cancer 87 2002 81 85
10. T. Fujisawa, J. Watanabe, M. Akaboshi, E. Ohno, and H. Kuramoto Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade J. Cancer Res. Clin. Oncol. 127 2001 668 674
11. J. Watanabe, Y. Kamata, T. Kanai, N. Seo, T. Fujisawa, Y. Nishimura, M. Hamano, T. Jobo, and H. Kuramoto Expression of cell cycle regulators in endometrial adenocarcinoma Cell and Molecular Biology of Endometrial Carcinoma 2003 Springer p. 93-106
12. FIGO news Corpus cancer staging Int. J. Gynecol. Obstet. 28 1989 189 193
13. C.L. Clarke, R.J. Zaino, P.D. Feil, J.V. Miller, M.E. Steck, B.M. Ohlsson-Wilhem, and P.G. Satyaswaroop Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques Endocrinology 121 1987 1123 1132
14. P.A. Mote, R.L. Balleine, E.M. McGowan, and C.L. Clarke Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle J. Clin. Endocrinol. Metab. 84 1999 2963 2971
15. T. Uchida, C. Wada, T. Shitara, S. Egawa, and K. Koshiba Infrequent involvement of p53 gene mutations in the tumorigenesis of Japanese prostate cancer Br. J. Cancer 68 1993 751 755
16. M. Orita, Y. Suzuki, T. Sekiya, and K. Hayashi Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction Genomics 5 1989 874 879
17. T. Shiozawa, H. Shih, T. Miyamoto, Y. Feng, J. Uchikawa, K. Itoh, and I. Konishi Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium J. Clin. Endocrinol. Metab. 88 2003 871 878
18. G.R. Attia, K. Zeitoun, D. Edwards, A. Johns, B.R. Carr, and S.E. Bulun Progesterone receptor isoform A but not B is expressed in endometriosis J. Clin. Endocrinol. Metab. 85 2000 2897 2902
19. R.B. Lathi, L. Swiersz, M. Basina, and L.C. Giudice The endometrum in policystic ovary syndrome Curr. Opin. Endocrinol. Diabetes 9 2002 480 485
20. R.L. Arnett-Mansfield, A. deFazio, G.V. Wain, R.C. Jaworski, K. Byth, P.A. Mote, and C.L. Clarke Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium Cancer Res. 61 2001 4576 4582
21. T. Jobo, K. Tateoka, and H. Kuramoto Study on the long-term follow-up of endometrial hyperplasia Int. J. Clin. Oncol. 1 3 1996 163 169
22. J. Alexieva-Figusch, P.W.L. Van, M.A. Blankenstein, D.W.J. Blonk-Van, and J.G. Klijn The prognostic value and relationship of patient characteristics, estrogen and progesterone receptors, and site of relapse in primary breast cancer Cancer 61 1988 758 768
23. K.B. Horwitz, and W.L. McGuire Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor J. Biol. Chem. 253 1978 2223 2228
24. M.E. Sherman Theories of endometrial carcinogenesis: a multidisciplinary approach Mod. Pathol. 13 3 2000 295 308
25. H. Yazii, and A.M. Gown Immunohistochemical analysis of gynecologic tumors Int. J. Gynecol. Oncol. 20 2001 64 78
26. A.A. Konski, D. Domenico, D.B.A. Irving, M. Tyrkus, J. Neisler, G. Phibbs, J. Mah, and W. Eggleston Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/ progesterone receptor status in endometrial adenocarcinoma Am. J. Clin. Oncol. 19 2 1998 164 168
27. K. Fukuda, M. Mori, M. Uchiyama, K. Iwai, T. Iwasaka, and H. Sugimori Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma Gynecol. Oncol. 69 1998 220 225
28. K.K. Leslie, N.S. Kumar, J. Richer, G. Owen, G. Takimoto, K. Horwitz, and C. Lange Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells Ann. N. Y. Acad. Sci. 828 1997 17 26
29. N.S. Kumar, J. Richer, G. Owen, E. Litman, K.B. Horwitz, and K.K. Leslie Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implication for unopposed estrogen action Cancer Res. 58 1998 1860 1865
30. J. Wang-Rodriguez, K. Cross, S. Gallagher, M. Djahanban, J.M. Armstrong, N. Wiedner, and D.H. Shapiro Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases Mod. Pathol. 15 8 2002 853 861
31. T. Inoue, J. Akahira, T. Suzuki, A.D. Darnel, C. Kaneko, K. Takahashi, M. Hatori, R. Shirane, T. Kumabe, Y. Kurokawa, S. Satomi, and H. Sasano Progesterone production and actions in the human central nervous system and neurogenic tumors J. Clin. Endocrinol. Metab. 87 11 2002 5325 5331
32. T. Yeh, Y. Jan, C. Chiu, Y. Ho, T. Chen, K. Lee, J. Hsu, T. Hwang, and M. Chen Characterization of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma Gut 51 2002 712 716
33. M. Sasaki, A. Dharia, B.R. Oh, Y. Tanaka, S. Fujimoto, and R. Dahiya Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer Cancer Res. 61 2001 97 102
34. Y. Chou, N. Uehara, J.R. Lowry, and G. Shyamala Mammary epithelial cells of PR-A transgenic mice exhibit distinct alterations in gene expression and growth potential associated with transformation Carcinogenesis 24 3 2003 403 409
35. J.P. Geisler, and H.E. Geisler Tumor markers and molecular biological markers in gynecologic malignancies Curr. Opin. Obstet. Gynecol. 13 2001 31 39
36. Y. Nakamura, H. Yasuoka, M. Tsujimoto, Q. Yang, A. Tsukiyama, S. Imabun, M. Nakahara, K. Nakao, M. Nakamura, I. Mori, and K. Kakudo Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up Mod. Pathol. 16 4 2003 309 314